European Lung Foundation

European Lung Foundation

The European Lung Foundation (ELF) is a patient-led organization founded in 2000 that works internationally to bridge the gap between patients, the public, and healthcare professionals to improve lung health. Operating in partnership with the European Respiratory Society (ERS), ELF aims to unite lung health professionals with those affected by lung disease and to advocate for better research, treatment, and public awareness of lung conditions. The foundation is dedicated to providing support, information, and a voice for people affected by lung disease through widespread networking with patient organizations across Europe and beyond. ELF fosters collaboration with local, national, and international patient groups, encouraging them to join an informal network promoting lung health.

ELF’s activities include campaign work for lung health, development of patient information, fostering research, and supporting patients’ communities. It has expanded its network significantly, adding about 40 organizations from 20 countries in recent years, including regions where it previously had limited contacts. By prioritizing multilingual support and cooperation with member societies of the ERS, ELF addresses regional patient needs and advocacy.

Registered as a private limited company by guarantee since February 2006, ELF’s mission focuses on prevention, treatment, and improvement of lung health quality of life, empowering patients, and upholding high standards of governance and effective operation. It invests in creating partnerships with relevant stakeholders and networks to enhance health outcomes and lung disease policies.

  • Company number: 05718525

  • Incorporated on: 22 February 2006

  • Company type: Private limited company by guarantee without share capital

  • Registered office address: 442 Glossop Road, Sheffield, S10 2PX

  • Nature of business: Other human health activities (SIC code 86900)

No related lobbyists found.

  • Health advocacy

  • Patient advocacy and support in lung disease

  • Research funding and promotion in respiratory diseases

  • Public health and lung disease prevention campaigns

  • European Respiratory Society (ERS)

  • Network of patient organizations across Europe, including 40 organizations from 20 countries recently joined

  • Local and national patient groups in countries such as Ukraine, Portugal, Turkey, Belgium, Serbia, Macedonia

  • International collaborations with patient organizations and research institutions

  • Exact financial lobbying expenditure since ELF’s registration up to June 2025 is not publicly detailed in accessible documents. The British Lung Foundation (a different but related organization) has reported millions in funding and campaigning efforts, but ELF’s dedicated lobbying expenses are not disclosed.

  • ELF is registered in the EU Transparency Register (exact registration number or details would be available on the EU register itself)

  • Engages mainly with health-related European Commission units, Members of European Parliament (MEPs) focused on health, and relevant EU agencies around lung health policy and research funding

  • Listings of individual meetings held by ELF with EU institutions are publicly available through the EU Transparency Register portal but are not detailed in the sources found here. According to the regular practice of such organizations, ELF meets with EU health policymakers, patient advocacy forums, and parliamentary committees to influence lung health policy.